Reuters logo
10 个月内
BRIEF-Avita Medical says FDA approves continued access to ReCell in US burns trial
2016年10月5日 / 凌晨1点12分 / 10 个月内

BRIEF-Avita Medical says FDA approves continued access to ReCell in US burns trial

1 分钟阅读

Oct 4 (Reuters) - Avita Medical Ltd

* US FDA approved continued access to ReCell, allowing US burns surgeons participating in co's regulatory trial to treat new patients using co's cell harvesting device

* Marketing application of ReCell is under preparation and review Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below